scholarly journals EFFECTS OF ADA INHIBITION ON T CELL DEVELOPMENT IN VITRO.: 8

1985 ◽  
Vol 19 (7) ◽  
pp. 745-745
Author(s):  
Randall W Barton
2013 ◽  
Vol 25 (10) ◽  
pp. 589-599 ◽  
Author(s):  
Monique F. M. A. Smeets ◽  
Charley Mackenzie-Kludas ◽  
Mahmood Mohtashami ◽  
Hui-Hua Zhang ◽  
Juan Carlos Zúñiga-Pflücker ◽  
...  

Immunity ◽  
1997 ◽  
Vol 6 (3) ◽  
pp. 245-255 ◽  
Author(s):  
Ricardo Cibotti ◽  
Jennifer A Punt ◽  
Krishna S Dash ◽  
Susan O Sharrow ◽  
Alfred Singer

Life Sciences ◽  
1989 ◽  
Vol 44 (13) ◽  
pp. v-xii ◽  
Author(s):  
J.W. Hadden ◽  
H. Chen ◽  
Y. Wang ◽  
A. Galy ◽  
E. Hadden

2019 ◽  
Vol 3 (3) ◽  
pp. 461-475 ◽  
Author(s):  
Ornellie Bernadin ◽  
Fouzia Amirache ◽  
Anais Girard-Gagnepain ◽  
Ranjita Devi Moirangthem ◽  
Camille Lévy ◽  
...  

Abstract T cells represent a valuable tool for treating cancers and infectious and inherited diseases; however, they are mainly short-lived in vivo. T-cell therapies would strongly benefit from gene transfer into long-lived persisting naive T cells or T-cell progenitors. Here we demonstrate that baboon envelope glycoprotein pseudotyped lentiviral vectors (BaEV-LVs) far outperformed other LV pseudotypes for transduction of naive adult and fetal interleukin-7–stimulated T cells. Remarkably, BaEV-LVs efficiently transduced thymocytes and T-cell progenitors generated by culture of CD34+ cells on Delta-like ligand 4 (Dll4). Upon NOD/SCIDγC−/− engraftment, high transduction levels (80%-90%) were maintained in all T-cell subpopulations. Moreover, T-cell lineage reconstitution was accelerated in NOD/SCIDγC−/− recipients after T-cell progenitor injection compared with hematopoietic stem cell transplantation. Furthermore, γC-encoding BaEV-LVs very efficiently transduced Dll4-generated T-cell precursors from a patient with X-linked severe combined immunodeficiency (SCID-X1), which fully rescued T-cell development in vitro. These results indicate that BaEV-LVs are valuable tools for the genetic modification of naive T cells, which are important targets for gene therapy. Moreover, they allowed for the generation of gene-corrected T-cell progenitors that rescued SCID-X1 T-cell development in vitro. Ultimately, the coinjection of LV-corrected T-cell progenitors and hematopoietic stem cells might accelerate T-cell reconstitution in immunodeficient patients.


2020 ◽  
Vol 88 ◽  
pp. S51
Author(s):  
Victoria Sun ◽  
Amelie Montel-Hagen ◽  
David Casero ◽  
Steven Tsai ◽  
Alexandre Zampieri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document